
1. Genes (Basel). 2018 Nov 28;9(12). pii: E584. doi: 10.3390/genes9120584.

Advances on Aptamers against Protozoan Parasites.

Ospina-Villa JD(1), López-Camarillo C(2), Castañón-Sánchez CA(3), Soto-Sánchez
J(4), Ramírez-Moreno E(5), Marchat LA(6).

Author information: 
(1)Grupo BCEI, Universidad de Antioquia, Medellín 050010, Colombia.
juando12358@gmail.com.
(2)Sección de Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad
de México, Ciudad de México 06720, Mexico. cesar.lopez@uacm.edu.mx.
(3)Hospital Regional de Alta Especialidad, Oaxaca 71294, Mexico.
ccastanon@hraeoaxaca.gob.mx.
(4)Sección de Estudios de Posgrado e Investigación, ENMH, Instituto Politécnico
Nacional, Ciudad de México 07738, Mexico. jakysotos@yahoo.com.mx.
(5)Sección de Estudios de Posgrado e Investigación, ENMH, Instituto Politécnico
Nacional, Ciudad de México 07738, Mexico. estherramirezmoreno@yahoo.com.
(6)Sección de Estudios de Posgrado e Investigación, ENMH, Instituto Politécnico
Nacional, Ciudad de México 07738, Mexico. lmarchat@gmail.com.

Aptamers are single-stranded DNA or RNA sequences with a unique three-dimensional
structure that allows them to recognize a particular target with high affinity.
Although their specific recognition activity could make them similar to
monoclonal antibodies, their ability to bind to a large range of non-immunogenic 
targets greatly expands their potential as tools for diagnosis, therapeutic
agents, detection of food risks, biosensors, detection of toxins, drug carriers, 
and nanoparticle markers, among others. One aptamer named Pegaptanib is currently
used for treating macular degeneration associated with age, and many other
aptamers are in different clinical stages of development of evaluation for
various human diseases. In the area of parasitology, research on aptamers has
been growing rapidly in the past few years. Here we describe the development of
aptamers raised against the main protozoan parasites that affect hundreds of
millions of people in underdeveloped and developing countries, remaining a major 
health concern worldwide, i.e. Trypanosoma spp., Plasmodium spp., Leishmania
spp., Entamoeba histolytica, and Cryptosporidium parvuum. The latest progress
made in this area confirmed that DNA and RNA aptamers represent attractive
alternative molecules in the search for new tools to detect and treat these
parasitic infections that affect human health worldwide.

DOI: 10.3390/genes9120584 
PMCID: PMC6316487
PMID: 30487456 

